E-LIB Suche - Ergebnisse für: Sachdev, Jasgit

1

A phase Ib study of adavosertib, a selective Wee1 inhibitor..:

Falchook, Gerald S ; Sachdev, Jasgit ; Imedio, Esteban Rodrigo...
Investigational New Drugs. 41 (2023) 3 - p. 493-502 , 2023

Link: https://doi.org/10.1007/..

2

DKK1 is a predictive biomarker for response to DKN-01: Resu..:

Arend, Rebecca ; Dholakia, Jhalak ; Castro, Cesar...
Gynecologic Oncology. 172 (2023) - p. 82-91 , 2023

Link: https://doi.org/10.1016/..

3

IOLite: phase 1b trial of doublet/triplet combinations of d..:

Yap, Timothy A ; Bessudo, Alberto ; Hamilton, Erika...
Journal for ImmunoTherapy of Cancer. 10 (2022) 3 - p. e003924 , 2022

Link: https://doi.org/10.1136/..

4

Patients with recurrent gynecologic cancers and Wnt activat..:

Arend, Rebecca ; Castro, Cesar ; Matulonis, Ursula...
Gynecologic Oncology. 162 (2021) - p. S16-S17 , 2021

Link: https://doi.org/10.1016/..

5

A first-in-human, phase 1, dose-escalation study of ABBV-17..:

Lemech, Charlotte ; Woodward, Natasha ; Chan, Nancy...
Investigational New Drugs. 38 (2020) 6 - p. 1815-1825 , 2020

Link: https://doi.org/10.1007/..

6

Phase 1 study of MRX34, a liposomal miR-34a mimic, in patie..:

Hong, David S. ; Kang, Yoon-Koo ; Borad, Mitesh...
British Journal of Cancer. 122 (2020) 11 - p. 1630-1637 , 2020

Link: https://doi.org/10.1038/..

7

A phase 1, open-label, dose-escalation trial of oral TSR-01..:

Lin, Chia-Chi ; Arkenau, Hendrik-Tobias ; Lu, Sharon...
British Journal of Cancer. 121 (2019) 2 - p. 131-138 , 2019

Link: https://doi.org/10.1038/..

8

Safety and pharmacokinetics of veliparib extended‐release i..:

Werner, Theresa L. ; Sachdev, Jasgit ; Swisher, Elizabeth M....
Cancer Medicine. 7 (2018) 6 - p. 2360-2369 , 2018

Link: https://doi.org/10.1002/..

9

P3.02c-027 Phase I and PK Study of the Folate Receptor-Targ..:

Edelman, Martin ; Sachdev, Jasgit ; Harb, Wael...
Journal of Thoracic Oncology. 12 (2017) 1 - p. S1288-S1289 , 2017

Link: https://doi.org/10.1016/..

10

Phase I study of MRX34, a liposomal miR-34a mimic, administ..:

Beg, Muhammad S. ; Brenner, Andrew J. ; Sachdev, Jasgit...
Investigational New Drugs. 35 (2016) 2 - p. 180-188 , 2016

Link: https://doi.org/10.1007/..

11

AKT in cancer: new molecular insights and advances in drug ..:

Mundi, Prabhjot S. ; Sachdev, Jasgit ; McCourt, Carolyn.
British Journal of Clinical Pharmacology. 82 (2016) 4 - p. 943-956 , 2016

Link: https://doi.org/10.1111/..

12

A pilot study utilizing multi-omic molecular profiling to f..:

Jameson, Gayle S. ; Petricoin, Emanuel F. ; Sachdev, Jasgit...
Breast Cancer Research and Treatment. 147 (2014) 3 - p. 579-588 , 2014

Link: https://doi.org/10.1007/..

13

Overcoming Taxane Resistance: Preclinical and Phase 1 Studi..:

Munster, Pamela N. ; Greenstein, Andrew E. ; Fleming, Gini F....
Clinical Cancer Research. 28 (2022) 15 - p. 3214-3224 , 2022

Link: https://doi.org/10.1158/..

14

Safety, antitumor activity, and pharmacokinetics of dostarl..:

Patnaik, Amita ; Weiss, Glen J. ; Rasco, Drew W....
Cancer Chemotherapy and Pharmacology. 89 (2021) 1 - p. 93-103 , 2021

Link: https://doi.org/10.1007/..

15

First-in-Human Study of PF-06647020 (Cofetuzumab Pelidotin)..:

Maitland, Michael L. ; Sachdev, Jasgit C. ; Sharma, Manish R....
Clinical Cancer Research. 27 (2021) 16 - p. 4511-4520 , 2021

Link: https://doi.org/10.1158/..